The Weill Cornell Medicine Comprehensive Thalassemia Center staff members are committed to the safety and well-being of our patients. For more information about COVID-19, here are links to other sources: the Weill Cornell COVID-19 patient guide, the Centers for Disease Control (CDC) website, the NYC Department of Health website, and the Cooley's Anemia Foundation website.
These sources provide up-to-date information on signs and symptoms, precautions to take, when to quarantine and other important tips. If you have developed a fever, cough, shortness of breath or other respiratory symptoms, please call your provider right away.
The New York Comprehensive Thalassemia Center has a rich history of research, both basic and clinical. Patients participate in single-center and multi-center trials of novel therapeutic agents, supported by the Clinical & Translational Science Center (CTSC) and overseen by the Institutional Review Board of Weill Cornell Medicine.
Open Clinical Trials
View and participate in ongoing clinical trials at the New York Comprehensive Thalassemia Center.